NCT03154840

Relative Bioavailability Among Different Eutropin Formulations

A Randomized, Open Label, Single Subcutaneous Dose 6x3 Crossover Study to Investigate the Relative Bioavailability Among Different Eutropin Formulations in Healthy Male Volunteers

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: LG Chem · Industry
• Sex: Male
• Age: 19 Years – 40 Years
• Healthy volunteers: Accepted

Summary

1. Compares and evaluates the relative bioavailability of single-dose subcutaneous administration of each of the Eutropin formulations to healthy male volunteers. 2. Ensure safety and tolerability of single, subcutaneous administration of Eutropin formulations to healthy male volunteers.

Conditions

• Relative Bioavailability

Interventions

Type	Name	Description
DRUG	Eutropin 4IU, Eutropin AQ 12IU, Eutropin Pen 36IU	Investigate the Relative Bioavailability among Different Eutropin Formulations

Timeline

• Start date: 2017-05-31
• Primary completion: 2017-07-10
• Completion: 2017-11-30
• First posted: 2017-05-16
• Last updated: 2017-07-21

Locations

1 site across 1 country: South Korea